CytRx Current Ratio 2010-2022 | CYTR
CytRx current ratio from 2010 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
CytRx Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2022-03-31 |
$0.01B |
$0.00B |
1.99 |
2021-12-31 |
$0.01B |
$0.00B |
2.22 |
2021-09-30 |
$0.02B |
$0.00B |
5.94 |
2021-06-30 |
$0.01B |
$0.00B |
3.53 |
2021-03-31 |
$0.01B |
$0.00B |
3.77 |
2020-12-31 |
$0.01B |
$0.00B |
4.12 |
2020-09-30 |
$0.02B |
$0.01B |
3.13 |
2020-06-30 |
$0.02B |
$0.00B |
6.59 |
2020-03-31 |
$0.02B |
$0.00B |
7.37 |
2019-12-31 |
$0.02B |
$0.00B |
8.39 |
2019-09-30 |
$0.02B |
$0.00B |
6.36 |
2019-06-30 |
$0.02B |
$0.00B |
10.73 |
2019-03-31 |
$0.02B |
$0.00B |
9.09 |
2018-12-31 |
$0.02B |
$0.00B |
8.78 |
2018-09-30 |
$0.03B |
$0.01B |
3.06 |
2018-06-30 |
$0.04B |
$0.02B |
2.30 |
2018-03-31 |
$0.04B |
$0.02B |
1.92 |
2017-12-31 |
$0.05B |
$0.03B |
1.56 |
2017-09-30 |
$0.05B |
$0.03B |
1.71 |
2017-06-30 |
$0.06B |
$0.02B |
2.44 |
2017-03-31 |
$0.05B |
$0.02B |
2.46 |
2016-12-31 |
$0.06B |
$0.02B |
3.11 |
2016-09-30 |
$0.06B |
$0.02B |
3.06 |
2016-06-30 |
$0.06B |
$0.02B |
3.81 |
2016-03-31 |
$0.07B |
$0.02B |
3.86 |
2015-12-31 |
$0.06B |
$0.02B |
2.80 |
2015-09-30 |
$0.07B |
$0.01B |
5.59 |
2015-06-30 |
$0.06B |
$0.02B |
2.96 |
2015-03-31 |
$0.07B |
$0.02B |
3.24 |
2014-12-31 |
$0.08B |
$0.02B |
4.68 |
2014-09-30 |
$0.10B |
$0.02B |
5.14 |
2014-06-30 |
$0.11B |
$0.02B |
4.67 |
2014-03-31 |
$0.11B |
$0.02B |
6.81 |
2013-12-31 |
$0.04B |
$0.03B |
1.33 |
2013-09-30 |
$0.02B |
$0.01B |
1.80 |
2013-06-30 |
$0.03B |
$0.01B |
3.30 |
2013-03-31 |
$0.03B |
$0.01B |
3.12 |
2012-12-31 |
$0.04B |
$0.01B |
3.94 |
2012-09-30 |
$0.02B |
$0.02B |
1.15 |
2012-06-30 |
$0.03B |
$0.03B |
1.04 |
2012-03-31 |
$0.03B |
$0.02B |
1.73 |
2011-12-31 |
$0.04B |
$0.01B |
2.74 |
2011-09-30 |
$0.04B |
$0.02B |
2.71 |
2011-06-30 |
$0.03B |
$0.01B |
4.18 |
2011-03-31 |
$0.03B |
$0.01B |
3.78 |
2010-12-31 |
$0.04B |
$0.01B |
5.87 |
2010-09-30 |
$0.04B |
$0.01B |
5.93 |
2010-06-30 |
$0.04B |
$0.01B |
7.63 |
2010-03-31 |
$0.04B |
$0.01B |
4.76 |
2009-12-31 |
$0.04B |
$0.01B |
4.99 |
2009-09-30 |
$0.04B |
$0.01B |
5.17 |
2009-06-30 |
$0.02B |
$0.00B |
5.81 |
2009-03-31 |
$0.02B |
$0.01B |
3.96 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$0.006B |
$0.000B |
CYTRX CORP. is engaged in the development and commercialization of pharmaceutical related products and services including human therapeutics focused on high-value critical- care therapies.
|